Modulation of the Cellular Accumulation and Intracellular Activity of Daptomycin towards Phagocytized Staphylococcus aureus by the P-Glycoprotein (MDR1) Efflux Transporter in Human THP-1 Macrophages and Madin-Darby Canine Kidney Cells
- 1 August 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (8) , 2748-2757
- https://doi.org/10.1128/aac.00090-07
Abstract
P-glycoprotein (P-gp; MDR1), a major efflux transporter, recognizes various antibiotics and is present in macrophages. We have examined its effect on the modulation of the intracellular accumulation and activity of daptomycin towards phagocytized Staphylococcus aureus (ATCC 25923) in human THP-1 macrophages, in comparison with MDCK epithelial cells (wild type and MDCK-MDR1 overexpressing P-gp; the bulk of the protein was immunodetected at the surface of all three cell types). Daptomycin displayed concentration-dependent intracellular activity (Hill equation pattern) in THP-1 and MDCK cells with (i) 50% effective drug extracellular concentration (EC 50 ; relative potency) and static concentrations at 9 to 10 times the MIC and (ii) maximal efficacy ( E max ; CFU decrease at infinite extracellular drug concentration) at 1.6 to 2 log compared to that of the postphagocytosis inoculum. Verapamil (100 μM) and elacridar (GF 120918; 0.5 μM), two known inhibitors of P-gp, decreased daptomycin EC 50 (about threefold) in THP-1 and MDCK cells without affecting E max . Daptomycin EC 50 was about three- to fourfold higher and accumulation in MDCK-MDR1 commensurately lower than in wild-type cells. In THP-1 macrophages, (i) verapamil and ATP depletion increased, and ouabain (an inducer of mdr1 [the gene encoding P-gp] expression) decreased the accumulation of daptomycin in parallel with that of DiOC 2 (a known substrate of P-gp); (ii) silencing mdr1 with duplex human mdr1 siRNAs reduced the cell content in immunoreactive P-gp to 15 to 30% of controls and caused an eight- to 13-fold increase in daptomycin accumulation. We conclude that daptomycin is subject to efflux from THP-1 macrophages and MDCK cells by P-gp, which reduces its intracellular activity against phagocytized S. aureus .Keywords
This publication has 73 references indexed in Scilit:
- Multiple drugbinding sites on the R482G isoform of the ABCG2 transporterBritish Journal of Pharmacology, 2006
- Cellular Accumulation and Activity of Quinolones in Ciprofloxacin-Resistant J774 MacrophagesAntimicrobial Agents and Chemotherapy, 2006
- Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 MacrophagesAntimicrobial Agents and Chemotherapy, 2006
- Bone Disease and HIV InfectionClinical Infectious Diseases, 2006
- Transmembrane Inhibitors of P-Glycoprotein, an ABC TransporterJournal of Medicinal Chemistry, 2005
- AcrB Multidrug Efflux Pump of Escherichia coli : Composite Substrate-Binding Cavity of Exceptional Flexibility Generates Its Extremely Wide Substrate SpecificityJournal of Bacteriology, 2003
- Azithromycin, a Lysosomotropic Antibiotic, Has Distinct Effects on Fluid-Phase and Receptor-Mediated Endocytosis, but Does Not Impair Phagocytosis in J774 MacrophagesExperimental Cell Research, 2002
- Ultrastructural localization of ras-related proteins using epitope-tagged plasmids.Journal of Histochemistry & Cytochemistry, 1995
- The human MDR3 P‐glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic miceFEBS Letters, 1994
- In vitro activity of LY146032 (Daptomycin), a new peptolideEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987